Identifying Neurophysiological Markers of Intermittent Theta Burst Stimulation in Treatment-Resistant Depression Using Transcranial Magnetic Stimulation-Electroencephalography
- PMID: 37084864
- DOI: 10.1016/j.biopsych.2023.04.011
Identifying Neurophysiological Markers of Intermittent Theta Burst Stimulation in Treatment-Resistant Depression Using Transcranial Magnetic Stimulation-Electroencephalography
Abstract
Background: Intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex is effective for treatment-resistant depression, but the effects of iTBS on neurophysiological markers remain unclear. Here, we indexed transcranial magnetic stimulation-electroencephalography (TMS-EEG) markers, specifically, the N45 and N100 amplitudes, at baseline and post-iTBS, comparing separated and contiguous iTBS schedules. TMS-EEG markers were also compared between iTBS responders and nonresponders.
Methods: TMS-EEG was analyzed from a triple-blind 1:1 randomized trial for treatment-resistant depression, comparing a separated (54-minute interval) and contiguous (0-minute interval) schedule of 2 × 600-pulse iTBS for 30 treatments. Participants underwent TMS-EEG over the left dorsolateral prefrontal cortex at baseline and posttreatment. One hundred fourteen participants had usable TMS-EEG at baseline, and 98 at posttreatment. TMS-evoked potential components (N45, N100) were examined via global mean field analysis.
Results: The N100 amplitude decreased from baseline to posttreatment, regardless of the treatment group (F1,106 = 5.20, p = .02). There were no changes in N45 amplitude in either treatment group. In responders, the N100 amplitude decreased after iTBS (F1,102 = 11.30, p = .001, pcorrected = .0004). Responders showed higher posttreatment N45 amplitude than nonresponders (F1,94 = 4.11, p = .045, pcorrected = .016). Higher baseline N100 amplitude predicted lower post-iTBS depression scores (F4,106 = 6.28, p = .00014).
Conclusions: These results provide further evidence for an association between the neurophysiological effects of iTBS and treatment efficacy in treatment-resistant depression. Future studies are needed to test the predictive potential for clinical applications of TMS-EEG markers.
Keywords: Electroencephalography; Major depressive disorder; Markers; TMS-EEG; iTBS; rTMS.
Copyright © 2023. Published by Elsevier Inc.
Comment in
-
Neurophysiological Biomarkers as a Springboard for the Refinement of Transcranial Magnetic Stimulation Therapy: Stratification, Mechanisms of Action, and Next Steps.Biol Psychiatry. 2023 Sep 15;94(6):443-444. doi: 10.1016/j.biopsych.2023.06.016. Biol Psychiatry. 2023. PMID: 37611984 No abstract available.
Similar articles
-
Neurophysiological effects of repetitive transcranial magnetic stimulation (rTMS) in treatment resistant depression.Clin Neurophysiol. 2021 Sep;132(9):2306-2316. doi: 10.1016/j.clinph.2021.05.008. Epub 2021 Jun 1. Clin Neurophysiol. 2021. PMID: 34167891 Clinical Trial.
-
Dose-response of intermittent theta burst stimulation of the prefrontal cortex: A TMS-EEG study.Clin Neurophysiol. 2022 Apr;136:158-172. doi: 10.1016/j.clinph.2021.12.018. Epub 2022 Jan 20. Clin Neurophysiol. 2022. PMID: 35183861
-
The effects of individualised intermittent theta burst stimulation in the prefrontal cortex: A TMS-EEG study.Hum Brain Mapp. 2019 Feb 1;40(2):608-627. doi: 10.1002/hbm.24398. Epub 2018 Sep 25. Hum Brain Mapp. 2019. PMID: 30251765 Free PMC article.
-
Toward the establishment of neurophysiological indicators for neuropsychiatric disorders using transcranial magnetic stimulation-evoked potentials: A systematic review.Psychiatry Clin Neurosci. 2020 Jan;74(1):12-34. doi: 10.1111/pcn.12936. Epub 2019 Nov 2. Psychiatry Clin Neurosci. 2020. PMID: 31587446
-
Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression.Adv Exp Med Biol. 2021;1305:333-349. doi: 10.1007/978-981-33-6044-0_18. Adv Exp Med Biol. 2021. PMID: 33834408 Review.
Cited by
-
Neurophysiological markers of disease severity and cognitive dysfunction in major depressive disorder: A TMS-EEG study.Int J Clin Health Psychol. 2024 Jul-Sep;24(3):100495. doi: 10.1016/j.ijchp.2024.100495. Epub 2024 Aug 30. Int J Clin Health Psychol. 2024. PMID: 39282218 Free PMC article.
-
Identifying neural circuitry abnormalities in neuropathic pain with transcranial magnetic stimulation and electroencephalogram co-registration.Neurotherapeutics. 2025 Mar;22(2):e00496. doi: 10.1016/j.neurot.2024.e00496. Epub 2024 Nov 28. Neurotherapeutics. 2025. PMID: 39613525 Free PMC article.
-
TMS-evoked potential in the dorsolateral prefrontal cortex to assess the severity of depression disease: a TMS-EEG study.Front Pharmacol. 2023 Jun 5;14:1207020. doi: 10.3389/fphar.2023.1207020. eCollection 2023. Front Pharmacol. 2023. PMID: 37342593 Free PMC article.
-
Neuroimaging Insights into the Public Health Burden of Neuropsychiatric Disorders: A Systematic Review of Electroencephalography-Based Cognitive Biomarkers.Medicina (Kaunas). 2025 May 28;61(6):1003. doi: 10.3390/medicina61061003. Medicina (Kaunas). 2025. PMID: 40572691 Free PMC article.
-
Enhancing prefrontal modulation by phase-locking intermittent theta burst stimulation to a concurrent transcranial alternating current stimulation.Imaging Neurosci (Camb). 2025 Jan 3;3:imag_a_00415. doi: 10.1162/imag_a_00415. eCollection 2025 Jan 3. Imaging Neurosci (Camb). 2025. PMID: 40433300 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical